Journal article icon

Journal article

A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO)

Abstract:

BACKGROUND: Elderly patients are commonly under-represented in cancer clinical trials. The 321GO was undertaken in preparation for a definitive phase three trial assessing different chemotherapy regimens in a frail and/or elderly population with advanced gastroesophageal (GO) cancer. METHODS: Patients with advanced GO cancer considered unfit for conventional dose chemotherapy were randomly assigned in a 1 : 1 : 1 ratio to: epirubicin, oxaliplatin and capecitabine (EOX); oxaliplatin and capeci...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/bjc.2016.442

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
Expand authors...
More from this funder
Grant:
Feasibility Study Project CRUK/08/033
Publisher:
Cancer Research UK Publisher's website
Journal:
British Journal of Cancer Journal website
Volume:
116
Issue:
4
Pages:
472-478
Publication date:
2017-01-17
Acceptance date:
2016-12-05
DOI:
EISSN:
1532-1827
ISSN:
0007-0920
Source identifiers:
671862
Language:
English
Keywords:
Pubs id:
pubs:671862
UUID:
uuid:20701c52-a940-4c72-9a94-633ba8e00e27
Local pid:
pubs:671862
Deposit date:
2017-05-16

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP